BB Biotech AG (BION) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.00x

BB Biotech AG (BION) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting CHF0.00 (capex CHF0.00 ) from operating cash flow of CHF373.71 Million. See BB Biotech AG (BION) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

CHF0.00
Capex + Investments

Operating Cash Flow

CHF373.71 Million
CHF

Capital Expenditures

CHF0.00
CHF

BB Biotech AG Cash Flow Reinvestment Rate (2004–2025)

Historical reinvestment intensity for BB Biotech AG across 15 annual periods. For the full cash flow conversion analysis, see BB Biotech AG (BION) cash flow conversion.

Annual Cash Flow Reinvestment Rate for BB Biotech AG (2004–2025)

Year-by-year capital reinvestment analysis for BB Biotech AG. See BB Biotech AG (BION) flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CHF) Operating CF Capex YoY Change
2025 0.00x CHF0.00 CHF309.14 Million CHF0.00
2024 0.00x CHF0.00 CHF304.56 Million CHF0.00
2023 0.00x CHF0.00 CHF218.28 Million CHF0.00
2020 0.00x CHF0.00 CHF262.45 Million CHF0.00
2019 0.00x CHF0.00 CHF215.02 Million CHF0.00
2017 0.00x CHF0.00 CHF687.50 Million CHF0.00
2015 0.00x CHF0.00 CHF652.82 Million CHF0.00
2014 0.00x CHF0.00 CHF1.47 Billion CHF0.00
2013 0.00x CHF0.00 CHF931.83 Million CHF0.00
2012 0.00x CHF0.00 CHF367.83 Million CHF0.00
2011 0.00x CHF0.00 CHF169.52 Million CHF0.00
2009 0.00x CHF0.00 CHF167.84 Million CHF0.00
2008 0.00x CHF0.00 CHF509.39 Million CHF0.00
2007 0.00x CHF0.00 CHF201.02 Million CHF0.00
2004 0.00x CHF0.00 CHF107.32 Million CHF0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow